Kate Hanna
CanadaexecutiveFemale6.0Global Dominance: 0.00%Kate Hanna is the director of communications at Novo Nordisk Canada, where she oversees communication strategies and public relations efforts for the company, particularly concerning its diabetes care products, including Ozempic.
Power1,507
Reach33,693
Country presence
Recent news mentions
Kate Hanna, director of communications at Novo Nordisk Canada, mentioned the stable supply of Ozempic for the Canadian market.
Apotex emerges as only supplier of generic Ozempic in Canada for nowThe Globe and Mail·Canada· 2026-07-29
Canada· 2026-07-29
